Praetego Inc

Harness the power of protection. Praetego develops new drugs to preserve health and protect patients from the complications of glucose dysregulation.

[Praetego Inc @PraetegoInc]

Thank you Alex - for inspiring everyone who sees this. We all benefit from seeing the remarkable power of combining the heart and mind. May this just be the beginning of a remarkable life in service. https://t.co/Xx7CxNtyr5

[Praetego Inc @PraetegoInc]

We are delighted and grateful to receive a significant Phase 2 STTR award from the NIDDK to continue our work to address serious diabetic complications.
The number of people affected by diabetes is many more than the count of pat…https://t.co/nLHxdTu4sL https://t.co/vizDCRf6cx

[Praetego Inc @PraetegoInc]

Praetego is honored and committed to offering a potential answer to COVID-19 Acute Kidney Injury - a serious & life threatening complication. We meet with BARDA on June 12th. We are #harnessingthepowerofprotection

[Praetego Inc @PraetegoInc]

Join @PraetegoInc as we pitch on March 18th at 4pm at the CED VentureConnectSummit @CEDNC at the Raleigh Convention Center. With many of our local life sci start-ups - we will showcase investment worthy innovation in NC.

[Praetego Inc @PraetegoInc]

As a company developing new drugs to treat serious diabetic complications for all diabetics - we are excited to see advances across the industry that benefit the patients. Insulet will connect Abbott, Dexcom CGMs with its digital, wearable insulin pump https://t.co/e943TOBLEb

[Praetego Inc @PraetegoInc]

A successful visit to NYC for BIO CEO&Investor Conference 2020. Interview at https://t.co/WPlKFmLQNH
Thanks to the many wonderful folks at https://t.co/Zud3hCaaVQ for creating an opportuity to showcase our novel candidates against serious diabetic complications.

[Praetego Inc @PraetegoInc]

@zcahill43 KHI is an incredible group of committed patients, scientists, clinicians, government partners, and industry members all sharing one mission - improving kidney health. @PraetegoInc is proud to be a member.

[Praetego Inc @PraetegoInc]

It's official. Praetego is now a portfolio company with Stony Lonesome Group. Thanks to Sean Drake and the team at SLG we are very proud to be part of the effort to improve the lives of active duty military and veterans with our drug candidates. Harness the Power of Protection!

[Praetego Inc @PraetegoInc]

Praetego receives green light from FDA to start clinical trials with PimoxIV for Cardiac-Surgery Induced Acute Kidney Injury (CS-AKI). We are Harnessing the Power of Protection!

[Praetego Inc @PraetegoInc]

It's official. Praetego wins it's first NIH NIDDK SBIR award. Amadorins to address Diabetic Peripheral Neuropathy program is launched. Thank you to all who made this possible.

[Praetego Inc @PraetegoInc]

Praetego to attend the Military Health Services Research Symposium at the Gaylord Conv Center in FL Aug 20-23 as we launch our TBI research program. https://t.co/GPVWHE172C

[Praetego Inc @PraetegoInc]

Our website goes live Aug18th. Check us out at https://t.co/FlfEgNM4kN.